Fluconazole-Related Hepatotoxicity in Patients With Acquired Immunodeficiency Syndrome

Archives of Internal Medicine

Volumn 151, Issue 5, 1991, Pages 1020-1021

  Munoz P ^a   Moreno, S ^a   Berenguer, J ^a   Quirós, J C L Bernaldo ^a   Bouza, E ^a  

^a NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; CANDIDIASIS; CASE REPORT; HUMAN; LETTER; LIVER TOXICITY; MALE; PRIORITY JOURNAL;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; CANDIDIASIS, ORAL; CASE REPORT; FLUCONAZOLE; HUMAN; LIVER; MALE;

EID: 0025736071     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.1991.00400050150032     Document Type: Letter

References (3)

1. Hay RH. Overview of studies of fluconazole in oropharyngeal candidiasis. Rev Infect Dis. 1990;12:S334-S337.
2. Sugar AM, Saunders C. Oral fluconazole as a suppressive therapy of disseminated cryptococcosis in patients with acquired immunodeficiency syndrome. Am J Med. 1988;85:481-489.
3. Fromtling RA. Overview of medically important antifungal azole derivatives. Clin Microbiol Res. 1988;1:187-216.